From: CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
Circular RNAs | Models or sample types | Regulation on expression | Targeted miRNA | Mechanism or effects on cancer progression | References |
---|---|---|---|---|---|
Circ-SETDB1 | SOC patients and healthy volunteers | Upregulated | – | It may act as a novel biomarker for finding SOC improvement and predicting reaction to platinum-taxane-combined chemotherapy and recurrence in SOC | Wang et al. [73] |
Circ-NFATC3 | OC cell lines | Upregulated | – | It may play a promising role in increasing cell proliferation, migration and invasion in OC | Karedathet al. [121] |
Circ-0015756 | OC and adjacent normal tissues OC cell lines | Upregulated | miR‑942-5p | Suppressing Circ-0015756 inhibits OC promotion through the regulation of miR-942-5p/CUL4B pathway Circ-0015756 may serve as a novel therapeutic target for OC | Du et al. [88] |
Circ-0002711 | OC tissues and cells OC tissues and cell lines | Upregulated | miR-1244 | Circ-0002711/miR-1244/ROCK1 pathway regulates tumor growth in vivo | Xie et al. [89] |
Circ-0015326 | Xenograft tumors in vivo | Upregulated | miR-127-3p | Circ-0015326 facilizes OC progression through absorbing and adjusting the miR-127-3p/MYB pathway Circ-0015326 may become a promising therapeutic target for OC | Zhang et al. [90] |
Circ-0025033 | OC tissues and cells | Upregulated | miR-330-5p | MiR-330-5p acts as a tumor suppressor in OC through targeting KLK4 Circ-0025033 may be a candidate in diagnosis and therapeutic target in OC | Cheng et al. [93] |
Circ-0025033 | OC tissues and cells | Upregulated | miR-184 | Circ-0025033 accelerates the progression of OC through regulating LSM4 expression by absorbing miR-184 It provides a new therapeutic strategy for OC | Hou and Zhang [92] |
Circ-MUC16 | EOC tissues and healthy ovarian tissues Cell lines | Upregulated | miR-199a | Circ-MUC16 promotes autophagy of EOC through absorbing miR-199a and regulation of ATG13 | Gan et al. [76] |
Circ-KRT7 | OC cell lines | Upregulated | miR-29a-3p | Circ-KRT7-miR-29a-3p-COL1A1 pathway increases tumorigenesis and promoting cell proliferation in OC | An et al. [139] |
Circ-0072995 | EOC tissues and cell lines | Upregulated | miR-147a | A novel diagnostic and therapeutic biomarker in OC It Enhances the progression of EOC via modulating miR-147a/CDK6 pathway | Ding et al. [31] |
Circ-FGFR3 | OC tissues and their adjacent normal tissues | Upregulated | miR-29a-3p | Regulating EMT of OC through miR-29a-3p/E2F1 pathway Its overexpression relates to poor prognosis in OC patients | Zhou et al. [83] |
Circ-PGAM | EOC tissues and cell lines | Upregulated | miR-542-3p | Circ-PGAM1 accelerates malignant progression of EOC by modulation of the miR-542-3p/CDC5L/PEAK1 axis | Zhang et al. [90] |
Circ-ABCB10 | EOC and adjacent normal tissues EOC cell lines | Upregulated | miR-1271 miR-1252 miR-203 | Circ-ABCB10 relates to advanced clinicopathological features and unfavorable survival It accelerates proliferation and reduce apoptosis through absorb of miR-1271, miR-1252 and miR-203 in EOC | Chen et al. [79] |
Circ-ABCB10 | EOC cells and normal epithelial ovarian cells | Upregulated | miR-1271 | Circ-ABCB10 expression is associated with weak differentiation, progressive FIGO stage, and large tumor size by guiding the miR-1271-mediated Capn4/Wnt/β-catenin signaling pathway | Lin et al. [84] |
Circ-HIPK3 | EOC tumor tissues and adjacent noncancerous tissues | Upregulated | – | Promoting proliferation, migration and invasion and inhibit apoptosis | Teng et al. [32] |
Circ-051239 | EOC tissues and exosomes derived from plasma and cells Cell lines in vitro | Upregulated | miR-509-5p | Superior metastatic EOC cells can admit this potential to lower metastatic potential through exosomal Circ-051239, generating raised proliferative, migratory and invasive inclusions in receptor cells | Ma et al. [44] |
Circ-EEF2 | OC cell lines and In vivo tumor xenograft | Upregulated | miR-6881-3p | Circ-EEF2 increasing autophagy through absorbing miR-6881-3p and ANXA2 in EOC | Yong et al. [81] |
Circ-RAB11FIP1 | EOC and normal tissue | Upregulated | miR-129 | Circ-RAB11FIP1 increasing autophagy of OC via DSC1 and miR-129 and may serve as a potential biomarker for EOC diagnosis and targeted therapy | Zhang et al. [82] |
Circ-KIF4A | OC tissues | Upregulated | miR-127 | Promoting OC progression via miR-127/JAM3 axis A promising novel biomarker and therapeutic target for OC | Sheng et al. [94] |
Circ‑FAM53B | OC specimens and cell lines | Upregulated | miR‑646 miR‑647 | Contributing to oncogenesis through sponging miR-646 and miR-647 leading proliferation, migration, and invasion in OC | Sun et al. [85] |
Circ-Foxp1 | Serum samples from EOC patients and healthy people | Upregulated | miR-22 miR-150-3p | Upregulated circulating exosomal Circ-Foxp1 is a self-determining prognosis of survival rate and drug resistance in EOC patients and can use as a novel biomarker and possible therapeutic target for EOC | Luo and Gui [107] |
Circ-S-7 | OC and normal adjacent tissues | Upregulated | miR-641 | Circ-S-7 promotes OC EMT by mediating miR-641 to up-regulate ZEB1 and MDM2 pathways | Luo and Gui [107] |
Circ-EPSTI1 | OC tissues and cell lines | Upregulated | miR‐942 | Circ-EPSTI1 adjusts OC promotion through decoying miR‐942 And can be serve as a biomarker and therapeutic target in OC | Xie et al. [89] |
Circ-0061140 | OC cell lines | Upregulated | miR-370 | Regulating cell proliferation in OC via mediation of the miR-370/ FOXM1 pathway | Chen et al. [79] |
VPS13C/Circ-001567 | Tumor and adjacent tissues OC cell lines | Upregulated | – | Knocking down of VPS13C/Circ-001567, reduces cell invasion, cell cycle, cell proliferation and apoptosis ability | Bao et al. [66] |
Circ-VPS13C | OC cells | Upregulated | miR-145 | Its Upregulation in OC Accelerates the progression of OC Circ-VPS13C/miR-145/MEK/ERK axis suppressed with the treatment of Propofol | Lu et al. [67] |
RAD50/ Circ-00718 | Tumor and adjacent tissues OC cell lines | Upregulated | – | It takes part in OC development via adjusting the biological behaviors of OC | Bao et al. [66] |
SPECC1/ Circ-000013 | Tumor and adjacent tissues and OC cell lines | Upregulated | – | It takes part in OC development via adjusting the biological behaviors of OC | Bao et al. [66] |
Circ-CSPP1 | OC tissues and cell lines | Upregulated | miR-1236-3p | Increasing ZEB1 expression, EMT related markers, MMP-2 and VEGFA factors which are belong to tumorigenesis Promoting cell proliferation and invasion by sponging miR-1236-3p | Li et al. [61] |
Circ-PIP5K1A | OC tissue and cell lines | Upregulated | miR-661 | It contributes OC progression through targeting the miR-661/IGFBP5 pathway Associated with poor prognosis | Sun et al. [77] |
Circ-CELSR1 | OC tissue and cell lines | Upregulated | miR-1252 | Increasing of Circ-CELSR1 is associated with enhanced drug resistance through Circ-CELSR1/miR-1252/FOXR2 axis | Zhang et al. [74] |
Circ-CELSR1 | OC tissue and cells | Upregulated | miR-149-5p | Reducing cell sensitivity in to drug resistance by regulating miR-149-5p/SIK2 pathway | Wei et al. [99] |
Circ-GFRA1 | OC tissues and adjacent normal tissues | Upregulated | miR-449a | It acts as a novel biomarker in prognosis and therapeutic targets | Liu et al. [55] |
Circ-0013958 | OC tissue and cell lines | Upregulated | – | Contributing OC promotion through affecting EMT and apoptosis Circ-0013958 may serve as a novel diagnostic and therapeutic target in OC | Pei et al. [71] |
Circ‑0005585 | Normal ovarian tissue Benign OC tissue Primary and metastatic EOC tissue | Upregulated | miR-23a miR-23b miR-15a miR-15b miR-16 | ESRP1 overexpression was regulated by Circ-0005585 via sponging miR-15a, miR-15b, miR-16, and miR-23a, miR-23b, which caused inhibition of cancer cells migration and metastasis | Deng et al. [58] |
Circ-102958 | OC tissue and cell lines | Upregulated | miR-1205 | Circ-102958 shows poor prognosis and promotes OC progression by miR-1205/SH2D3A pathway | Wang et al. [59] |
Circ-MYLK | tumor tissue specimens and paracancerous normal ones | Upregulated | miR-652 | Developing malignancy progression of OC through absorbing miR-652 associating with pathological staging and poor prognosis in OC patients | Zhao et al. [60] |
Circ-PUM1 | OC tissues Normal tissues Cell lines | Upregulated | miR-615-5p miR-6753-5p | It acts as a cancer derive exosome Promoting OC proliferation and migration | Guan et al. [72] |
Circ-RhoC | OC tissues Normal tissues Cell lines | Upregulated | miR-302e | Accelerating tumorigenicity via positive regulation of miR-302e/VEGFA axis | Wang et al. [59] |
Circ-0000714 | OC cells Cell lines | Upregulated | miR-370-3p | Controlling and Regulating RAB17/CDK6/RB axis which progress in the malignancy of the paclitaxel-resistant OC cells | Guo et al. [100] |
Circ-TNPO3 | OC samples and correlated with PTX resistance | Upregulated | miR-1299 | It plays a fundamental role in the chemoresistance and tumorigenesis of OC through upregulating NEK2 expression | Xia et al. [101] |
Circ-NRIP1 | Tumor xenograft models | Upregulated | miR-211-5p | It increasingly expresses in PTX-resistant OC tissues and cells Suppressing of Circ-NRIP, inhibited the PTX resistance in OC through modulating the miR-211-5p/HOXC8 pathway It may act as a prominent novel target in resistance therapy | Li et al. [102] |
Circ-UBAP2 | OC tissues and adjacent normal tissues | Upregulated | miR-144 | Promoting OC progression via sponging miR-144 | Sheng et al. [94] |
Circ-UBAP2 | OC tissues and cell lines | Upregulated | miR-382-5p | Promoting proliferation, migration and invasion and inhibit apoptosis | Xu et al. [95] |
Circ-0001068 | OC patients and healthy volunteers | Upregulated | miR-28-5p | Circ-0001068 was higher in OC patients than healthy ones Play as a prominent noninvasive biomarker and aim for the diagnosis and therapeutic targets in OC | Wang et al. [106] |
Circ-NOLC1 | OC tissues Normal tissues Cell lines | Upregulated | miR-326-5p miR-330 miR-370 miR-9-5p | Increasing cell growth, migration, invasion, and playing an oncogenic role by attaching ESPR1, RhoA, and modulating CDK1 levels | Chen et al. [108] |
Circ-PVT1 | EOC cell lines and Normal control cells | Upregulated | miR-149 | Accelerating cell proliferation hindering apoptosis | Sun et al. [85] |
Circ-PVT1 | OC tissue and normal tissue | Upregulated | miR-149-5p | Increasing of PVT1 levels causes shorter survival rate in OC patients Increasing FOXM1 level through binding to miR-149-5p Causing OC cell viability and migration | Li et al. [86] |
Circ-ASH2L | OC cells in vitro Tumor xenografts in vivo | Upregulated | miR-665 | Acting as a serious role in adjusting OC cell tumorigenesis, lymphangiogenesis and angiogenesis by the miR-665/VEGFA pathway It is a thinkable candidate for therapeutic targets in OC | Chen et al. [79] |
Circ-0051240 | OC and corresponding adjacent non-cancerous tissues | Upregulated | miR-637 | Boosting cell proliferation, migration and invasion in OC by miR-637/KLK4 pathway | Zhang et al. [82] |
Circ-SMAD7 | OC cells and tissue | Upregulated | miR-630 | Circ-SMAD7/miR-630/KLF axis causing oncogenic behavior in OC | Zhao et al. [109] |
Circ_0026123 | OC cell lines and tissues | Upregulated | miR‑124‑3p | Increasing OC cells metastasis and proliferation via the miR‑124‑3p/EZH2 axis | Yang et al. [25] |
Circ-WHSC1 | normal ovaries and OC tissues | Upregulated | miR-145 miR-1182 | Increasing expression of Circ-WHSC1 in OC promotes tumorigenesis via modulation of miR-145 and miR-1182 | Zong et al. [64] |
Circ-0009910 | OC tissues Normal ovarian tissues OC cell lines | Upregulated | miR-145 | Circ-0009910, representing poor prognosis in OC cells Inducing proliferation and motility through suppressing miR-145 | Li et al. [65] |
Circ-0002711 Circ-0001756 | OC patient serum | Upregulated | – | These CircRNAs are presumably related to OC promotion, and may be promising novel biomarkers | Wang et al. [73] |
Circ-0004390 | OC tissue and normal tissue | Upregulated | miR-198 | Circ-0004390 proliferation through miR-198/MET pathway, provides a therapeutic novel target for OC | Xu et al. [57] |
Circ-1656 | SOC tissues and ovarian cell lines | Downregulated | – | Acting as a promising biomarker and significantly associated with SOC FIGO stage | Gao et al. [112] |
Circ-ITCH | Tumor tissues and paired adjacent tissues samples | Downregulated | – | Suppressing cells proliferation Increases cells apoptosis in EOC | Luo et al. [116] |
Circ-ITCH | Human EOC cell lines human normal ovarian epithelial cell line | Downregulated | miR-10a-α | Suppressing cells proliferation Increases cells apoptosis in EOC | Luo et al. [116] |
Circ-ITCH | OC tissues and cell lines | Downregulated | miR-145 | Suppressing the malignancy of OC cells through the circ-ITCH-miR-145-RASA1 pathway | Hu et al. [113] |
Circ-ITCH | OC tissues and cell lines | Downregulated | HULC-lncRNA | It’s downregulation of OC with the mediate of HULC lncRNA | Yan et al. [118] |
Circ-9119 | OC tissues and cell lines | Downregulated | miR-21 | Regulating OC cells proliferation and apoptosis through absorbing miR-21 and targeting the PTEN–Akt axis | Gong et al. [120] |
Circ-LARP4 | OC tissue and adjacent normal tissue samples | Downregulated | – | It’s Low expression in OC patients, makes it a novel prognostic biomarker | Zou et al. [122] |
CDR1as | OC and EOC tissues and cell lines | Downregulated | miR-135b-5p | By intermediation of miR-135-5p/ HIF1AN pathway, suppressing tumor formation | Chen et al. [131] |
Cdr1as | OC tissues and cell lines | Downregulated | miR-1270 | Reducing OC cells drug resistance by upregulation of SCAI and downregulation of miR-1270 | Zhao et al. [109] |
Circ-EXOC6B | EOC specimens and normal ovarian tissues | Downregulated | – | It can play a role as a potential prognostic biomarkers in patients with EOC | Ning et al. [110] |
Circ-EXOC6B | OC cells in vitro OC cells in vivo | Downregulated | miR-376c-3p | Increasing sensitivity of drug resistance of OC cells Decreasing proliferation, migration and invasion of OC cells through miR-376c-3p/FOXO3 axis | Zheng et al. [114] |
Circ-EXOC6B | Normal ovarian epithelial cells Human OC cell lines | Downregulated | miR-421 | Promising target for the treatment of OC via sponging miR-421 and upregulating RSU1 | Wang et al. [115] |
Circ-BNC2 | OC tissue and plasma samples | Downregulated | – | Potential diagnostic biomarkers in patients with EOC | Hu et al. [113] |
Circ-RHOBTB3 | OC cells in vitro OC cells in vivo | Downregulated | – | Suppressing cell proliferation and metastasis through PI3K/AKT signaling pathway | Hu et al. [113] |
Circ-PLEKHM3 | Primary OC/metastatic OC/normal ovarian tissues/cell lines | Downregulated | miR-9 | Targeting miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis Inactivates the PI3K/AKT and Wnt/catenin pathways via promoting BRCA1, DNAJB6a, and KLF4 expression by sponging miR-9 | Zhang et al. [123] |
Circ-0007444 | OC patients and OC cells | Downregulated | miR-570-3p | Circ-0007444 suppressing OC promotion through the miR-570-3p/PTEN pathway It may serve as a candidacy for targeted therapy | Wu et al. [140] |
Circ-ANKRD12 | OC cell lines | Downregulated | miR-4768-5p | Expression of Circ-ANKRD12, suppresses invasive molecular behaviors and phenotypes Circ-ANKRD12 can act in a various set of tasks ranging from cell cycle arrest, tumor invasion to immune incorporation | Karedath et al. [121] |
Circ-0078607 | OC tissues and adjacent tissues OC cell lines | Downregulated | miR-518a-5p | Circ-0078607 downregulation, inhibits OC progression through miR-518a-5p/Fas axis | Zhang et al. [123] |
Circ-0007874 | OC cell lines | Downregulated | miR-760 | Circ-0007874 downregulation, inhibits OC progression through miR-760/SOCS3 pathway | Li et al. [125] |
Circ-MTO1 | OC tissues and adjacent tissues OC cell lines | Downregulated | miR-182-5p | Circ-MTO1 suppresses the proliferation and invasion of OC cells via the miR-182-5p/KLF15 pathway | Wang et al. [115] |
Circ-100395 | OC tissues | Downregulated | miR-1228 | Circ-100395 suppresses cell proliferation and metastasis of OC cells through regulating the miR-1228/p53/EMT pathway | Li et al. [125] |